Nox Medical announced the introduction of Nox A1s PSG system with telehealth capabilities to perform in-lab and at-home sleep testing to enable sleep specialists to support scalable clinical pathways and assist a greater number of individuals in achieving improved sleep, improving patient comfort, clinical accuracy, and overall efficiency in mind.
ResMed teamed up with Bittium Biosignals Ltd, under which ResMed becomes a distributor of Bittium Respiro the advanced Home Sleep Apnea Test and Analysis Solution including Bittium Respiro measuring device and its accessories, as well as Bittium Respiro Analyst software analyzing tool and service platform that focuses on measuring nighttime polygraphy at home to record and assesses typical cases of sleep-disordered breathing by using artificial intelligence to improve the analysis process's efficiency.
Author Credits: Radhika Gupta, Shivam Bhutani
Report ID: 5500
Published Date: Jan 05, 2024
Report Format: PDF, PPT
Frequently Asked Questions (FAQ)
Lack of sleep prevalence across the globe and the growing awareness about sleep disorders are the major factors driving the growth of the market.
The market size of polysomnography devices is anticipated to attain a CAGR of 5% over the forecast period, i.e., 2024-2036.
The major players in the market are BMC Medical, CleveMed, Recorders & Medicare Systems, Medicom MTD, Compumedics, Dr. Langer Medical, Neurovirtual, Shanghai NCC Medica, Contec Medical Systems, CleveMed, SOMNOmedics GmbH, Cidelec, and others.
The fixed segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.
The market in the North American region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.